STEPHEN A. BESH, M.D.

Plain English
This study looks at esophageal and esophagogastric junction cancers, which are becoming increasingly common, especially in North America and Western Europe. It found that adding treatments like chemotherapy and radiation before surgery can significantly improve survival rates for patients whose cancer can still be surgically removed. Additionally, new targeted treatments, such as trastuzumab and ramucirumab, show promise for patients with advanced cancer. Who this helps: This research benefits patients with esophageal and esophagogastric junction cancers by offering better treatment options.

Plain English
The study reviewed updated guidelines for treating gastric cancer, emphasizing a team-based approach for managing patients. It found that patients with operable cancer should undergo surgery to remove the stomach and nearby lymph nodes, ideally by skilled surgeons in experienced hospitals. For certain patients, chemotherapy and radiation after surgery are recommended to improve outcomes, especially if the cancer is at a more advanced stage. Who this helps: This benefits patients with gastric cancer and their healthcare providers.

Plain English
This study explored a targeted cancer treatment using a special protein designed to locate and attack tumor cells in patients with advanced colorectal cancer. Nine patients received a new fusion protein and subsequent doses of a radioactive agent, which successfully delivered radiation primarily to tumors while sparing healthy tissue, achieving a remarkable tumor-to-bone marrow radiation dose ratio of 139 to 1. The findings indicate this method is not only safe but may be effective in treating tumors that express the TAG-72 marker, paving the way for enhanced cancer therapies. Who this helps: This helps patients with metastatic colorectal cancer.

Plain English
This study looked at people infected with the filarial parasite Wuchereria bancrofti in Brazil, even though they had no symptoms. Researchers found that these asymptomatic infected individuals had abnormal lymphatic function, showing faster lymph fluid movement compared to healthy people—specifically, 19.8 minutes versus 37.7 minutes for fluid clearance. These findings suggest that we need to rethink how we approach treatment in order to prevent future health problems related to this infection. Who this helps: This helps patients with filarial infections and healthcare providers treating them.

Plain English
This study examined the lymphatic system of 36 people in Brazil who had a parasitic infection called filariasis, some of whom showed symptoms while others did not. Researchers found that even those without symptoms had significant lymphatic abnormalities, challenging the old belief that only symptomatic individuals were affected. This matters because it highlights the need for better diagnostic methods and treatment strategies for everyone with this infection, regardless of their symptoms. Who this helps: This helps patients with filariasis by leading to more effective treatment options.